| Serial Number | 87806064 |
| Word Mark | ULTRAGENYX GENE THERAPY |
| Filing Date | Wednesday, February 21, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 16, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 12, 2019 |
| Description of Mark | The mark consists of the word "ultragenyx" in lower case letters above the words "gene therapy". The formative "ultra" and the words "gene therapy" are purple and the formative "genyx" is green. The letter "x" in "genyx" is stylized and features an enlongated stroke reaching above and below the word "ultragenyx". A gray hexagon is below the formative "ultra" and to the left of the words "gene therapy." A double helix, one strand of which is purple and one strand of which is green, is vertically oriented inside the gray hexagon. |
| Goods and Services | Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, inflammatory, autoimmune, musculoskeletal, ophthalmologic, respiratory, and hematologic diseases and disorders |
| Indication of Colors claimed | The color(s) purple, green and gray is/are claimed as a feature of the mark. |
| Goods and Services | Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo laboratory use in gene therapy |
| Goods and Services | Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, respiratory, and hematologic diseases and disorders |
| Disclaimer with Predetermined Text | "GENE THERAPY" |
| Goods and Services | Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 28, 2018 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 28, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 28, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 28, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Event Date | Event Description |
| Monday, May 16, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, May 16, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, October 28, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 27, 2021 | SOU EXTENSION 5 GRANTED |
| Monday, October 4, 2021 | SOU EXTENSION 5 FILED |
| Wednesday, October 6, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, October 4, 2021 | TEAS EXTENSION RECEIVED |
| Saturday, March 27, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 25, 2021 | SOU EXTENSION 4 GRANTED |
| Thursday, March 25, 2021 | SOU EXTENSION 4 FILED |
| Thursday, March 25, 2021 | TEAS EXTENSION RECEIVED |
| Wednesday, September 30, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 28, 2020 | SOU EXTENSION 3 GRANTED |
| Monday, September 28, 2020 | SOU EXTENSION 3 FILED |
| Monday, September 28, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, March 31, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, March 27, 2020 | SOU EXTENSION 2 GRANTED |
| Friday, March 27, 2020 | SOU EXTENSION 2 FILED |
| Friday, March 27, 2020 | TEAS EXTENSION RECEIVED |
| Thursday, October 3, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 1, 2019 | SOU EXTENSION 1 GRANTED |
| Tuesday, October 1, 2019 | SOU EXTENSION 1 FILED |
| Tuesday, October 1, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, April 9, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 12, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 12, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 23, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 4, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 26, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 26, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 26, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 26, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, December 12, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 11, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 11, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 12, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 12, 2018 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 12, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 5, 2018 | ASSIGNED TO EXAMINER |
| Friday, March 2, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, February 28, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, February 24, 2018 | NEW APPLICATION ENTERED IN TRAM |